KPP Advisory Services LLC reduced its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report) by 10.5% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 10,182 shares of the pharmacy operator’s stock after selling 1,197 shares during the quarter. KPP Advisory Services LLC’s holdings in Walgreens Boots Alliance were worth $95,000 at the end of the most recent reporting period.
A number of other institutional investors have also made changes to their positions in the business. The Manufacturers Life Insurance Company boosted its stake in shares of Walgreens Boots Alliance by 2.1% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 436,849 shares of the pharmacy operator’s stock worth $5,284,000 after buying an additional 8,973 shares during the last quarter. Cetera Investment Advisers increased its position in shares of Walgreens Boots Alliance by 4.4% during the 2nd quarter. Cetera Investment Advisers now owns 364,734 shares of the pharmacy operator’s stock worth $4,411,000 after purchasing an additional 15,270 shares during the last quarter. Sanctuary Advisors LLC bought a new stake in shares of Walgreens Boots Alliance during the 2nd quarter worth approximately $313,000. Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in shares of Walgreens Boots Alliance in the 2nd quarter valued at approximately $958,000. Finally, Massmutual Trust Co. FSB ADV raised its position in Walgreens Boots Alliance by 96.8% during the third quarter. Massmutual Trust Co. FSB ADV now owns 5,527 shares of the pharmacy operator’s stock worth $50,000 after acquiring an additional 2,719 shares in the last quarter. Institutional investors own 58.59% of the company’s stock.
Wall Street Analyst Weigh In
WBA has been the topic of several recent analyst reports. Truist Financial lowered their price objective on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research note on Friday. Evercore ISI lifted their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research note on Monday, January 13th. Royal Bank of Canada raised their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a report on Wednesday, January 15th. Barclays lifted their price target on Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a report on Wednesday, October 16th. Finally, UBS Group lifted their price objective on Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a report on Thursday, October 17th. Four research analysts have rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, Walgreens Boots Alliance presently has a consensus rating of “Hold” and a consensus target price of $13.19.
Walgreens Boots Alliance Stock Performance
Walgreens Boots Alliance stock opened at $9.76 on Tuesday. The business has a 50 day moving average of $10.12 and a 200-day moving average of $9.84. The company has a market capitalization of $8.43 billion, a P/E ratio of -0.95, a P/E/G ratio of 1.28 and a beta of 0.64. Walgreens Boots Alliance, Inc. has a 1 year low of $8.08 and a 1 year high of $23.76. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30.
Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) last posted its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. During the same period in the previous year, the firm earned $0.66 earnings per share. The firm’s quarterly revenue was up 7.6% on a year-over-year basis. On average, equities research analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Read More
- Five stocks we like better than Walgreens Boots Alliance
- 3 Best Fintech Stocks for a Portfolio Boost
- How to Invest in Small Cap Stocks
- 3 Warren Buffett Stocks to Buy Now
- These Are the Dividend Stocks Insiders Bought in January
- Using the MarketBeat Stock Split Calculator
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.